09:01 AM EDT, 05/01/2025 (MT Newswires) -- Cipher Pharmaceuticals ( CPHRF ) on Thursday filed, and the Toronto Stock Exchange has accepted, notice of its intention to commence a normal course issuer bid for its common shares.

The TSX notice provides that Cipher may, during the 12-month period commencing May 5, 2025 and ending on May 4, 2026, purchase for cancellation under the NCIB up to 1,485,260 of its common shares, representing 10% of its public float of 14,852,604 common shares as of April 22, 2025 (a total of 25,622,940 common shares were issued and outstanding as of such date). The price which Cipher will pay for any common shares will be the market price at the time of acquisition.

CPH edged up $0.14 or 1.05% on the TSX yesterday.